AI for Biostatisticians
Also known as: Statistical Scientist, Senior Biostatistician
This role isn't yet mapped to specific AI applications in our industry library. The day-to-day breakdown below is the authored view of the work.
A Day in the Life
How AI changes daily work for Biostatisticians
You design the statistical backbone of clinical trials — sample sizes, randomization schemes, analysis plans, and the regulatory-grade analyses that determine if a drug works. The FDA reads your tables before anything else.
Sorted by impact — tasks changing the most are at the top.
Perform sample size calculationAutomates✓ Now
What you do today
Estimate required sample size based on effect size, variability, power, alpha — account for dropout, interim analyses, adaptive design elements
AI that applies
AI simulates thousands of trial scenarios to optimize sample size under various assumptions about effect size, dropout rates, and enrollment patterns
How it works
For perform sample size calculation, the system draws on the relevant operational data and applies the appropriate analytical models. The simulation engine runs thousands of scenarios by varying each uncertain input across its probability range, building a distribution of outcomes that quantifies the risk. The results integrate into the practitioner's existing workflow — presenting recommendations, flags, or automated outputs alongside their normal working context.
What Changes
Simulation-based sample sizing runs thousands of scenarios automatically instead of manual sensitivity tables; identifies the most efficient design
What Stays
You choose the assumptions, interpret regulatory acceptability of adaptive designs, and defend the sample size rationale to FDA
Review CDISC dataset specificationsAutomates✓ Now
What you do today
Ensure SDTM and ADaM datasets comply with CDISC standards, review dataset specs with data management, validate derivation logic
AI that applies
AI validates CDISC compliance automatically, flags deviations from SDTM/ADaM standards, and suggests conformant variable mappings
How it works
The system ingests SDTM/ADaM standards as its primary data source. The processing layer applies the appropriate analytical models to the structured data, generating scored outputs that surface the most actionable insights. The results integrate into the practitioner's existing workflow — presenting recommendations, flags, or automated outputs alongside their normal working context.
What Changes
CDISC validation is automated and comprehensive; AI catches compliance issues that manual review might miss across hundreds of variables
What Stays
You make decisions about custom domains, non-standard variables, and how to handle edge cases that don't fit standard CDISC models
Validate statistical programming outputAutomates✓ Now
What you do today
Independently program key analyses as QC check against primary programmer, reconcile discrepancies, ensure double-programming compliance
AI that applies
AI assists with independent QC programming, automatically compares outputs, and identifies discrepancies at the cell level in TFLs
How it works
For validate statistical programming output, the system identifies discrepancies at the cell level in tfls. The processing layer applies the appropriate analytical models to the structured data, generating scored outputs that surface the most actionable insights. The results integrate into the practitioner's existing workflow — presenting recommendations, flags, or automated outputs alongside their normal working context.
What Changes
QC programming is faster; AI automatically highlights discrepancies between primary and QC outputs instead of manual comparison
What Stays
You investigate discrepancies, determine root cause, and ensure the final validated output is correct — accuracy is non-negotiable
Design randomization schemeEnhances✓ Now
What you do today
Define stratification factors, block sizes, randomization ratios — balance scientific rigor with operational feasibility across trial sites
AI that applies
AI optimizes stratification and dynamic randomization (minimization) parameters to maximize balance across prognostic factors
How it works
For design randomization scheme, the system draws on the relevant operational data and applies the appropriate analytical models. The processing layer applies the appropriate analytical models to the structured data, generating scored outputs that surface the most actionable insights. The results integrate into the practitioner's existing workflow — presenting recommendations, flags, or automated outputs alongside their normal working context.
What Changes
AI simulates enrollment scenarios to identify which stratification factors matter most and optimal block sizes for your site structure
What Stays
You decide the randomization strategy based on regulatory precedent, site capabilities, and clinical considerations
Run interim analysis for Data Safety Monitoring BoardEnhances✓ Now
What you do today
Execute pre-planned interim analysis, prepare DSMB report with futility/efficacy boundaries, present results under strict unblinding protocols
AI that applies
AI automates DSMB report generation from clinical database, performs group sequential calculations, and generates standardized safety tables
How it works
The system ingests clinical database as its primary data source. The processing layer applies the appropriate analytical models to the structured data, generating scored outputs that surface the most actionable insights. The output — standardized safety tables — surfaces in the existing workflow where the practitioner can review and act on it.
What Changes
Report generation is faster and more standardized; AI ensures all pre-specified analyses are included without manual checklist review
What Stays
You ensure statistical integrity of the interim analysis, maintain the firewall, and present results with appropriate caveats to the DSMB
Perform primary efficacy analysis for CSREnhances✓ Now
What you do today
Execute the pre-specified primary analysis from the SAP, run sensitivity analyses, produce TFLs (tables, figures, listings) for the clinical study report
AI that applies
AI-assisted programming generates validated TFLs faster, automatically QC's output against SAP specifications, and flags discrepancies
How it works
For perform primary efficacy analysis for csr, the system draws on the relevant operational data and applies the appropriate analytical models. The processing layer applies the appropriate analytical models to the structured data, generating scored outputs that surface the most actionable insights. The output — validated TFLs faster — surfaces in the existing workflow where the practitioner can review and act on it.
What Changes
TFL programming is faster with AI code generation; AI validates output against SAP and catches programming errors before peer review
What Stays
You interpret the results, write the statistical interpretation, and determine if the trial met its primary objective
Write Statistical Analysis Plan for Phase III trialEnhances◐ 1–3 yrs
What you do today
Define primary endpoint analysis, handling of missing data, multiplicity adjustments, sensitivity analyses, subgroup analyses — document in ICH E9-compliant SAP
AI that applies
AI drafts SAP sections from protocol parameters, suggests appropriate statistical methods based on endpoint type, and ensures ICH E9(R1) compliance
How it works
The system ingests protocol parameters as its primary data source. A language model processes the input by identifying relevant context, generating appropriate responses, and structuring the output to match the expected format and domain conventions. The output is a recommended plan or schedule that accounts for the identified constraints and optimization criteria.
What Changes
First draft SAP generated in hours; AI suggests best-practice analysis approaches for your specific endpoint and design
What Stays
You make the statistical design decisions — primary analysis method, estimand framework, missing data approach — these require deep statistical judgment
Handle missing data analysisEnhances◐ 1–3 yrs
What you do today
Implement missing data methods (MMRM, multiple imputation, pattern-mixture models, tipping point analyses) per ICH E9(R1) estimand framework
AI that applies
AI automates sensitivity analyses across multiple missing data assumptions, generates tipping point analysis results, and visualizes impact on conclusions
How it works
The system ingests across multiple missing data assumptions as its primary data source. A language model processes the input by identifying relevant context, generating appropriate responses, and structuring the output to match the expected format and domain conventions. The output — tipping point analysis results — surfaces in the existing workflow where the practitioner can review and act on it.
What Changes
Running 20 sensitivity analyses instead of 5 becomes feasible; AI comprehensively tests robustness of conclusions to missing data assumptions
What Stays
You define the estimand, choose the primary missing data approach, and interpret whether the results are robust — regulatory judgment is key
Consult with clinical team on trial designEnhances◐ 1–3 yrs
What you do today
Advise on endpoint selection, design trade-offs (parallel vs crossover, superiority vs non-inferiority), power implications of design choices
AI that applies
AI simulates trial outcomes under different design options, quantifying trade-offs in power, cost, and timeline for each alternative
How it works
The system ingests clinical data — patient records, lab results, vitals, and care history from the EHR. A language model processes the input by identifying relevant context, generating appropriate responses, and structuring the output to match the expected format and domain conventions. The results integrate into the practitioner's existing workflow — presenting recommendations, flags, or automated outputs alongside their normal working context.
What Changes
You bring quantified trade-offs to design discussions instead of conceptual arguments; AI shows 'if we switch to crossover, power increases 12% but dropout risk rises'
What Stays
You provide the statistical judgment that balances scientific rigor with operational reality and regulatory expectations
Prepare for FDA statistical review meetingEnhances◐ 1–3 yrs
What you do today
Anticipate FDA statistical reviewer questions, prepare backup analyses, build defense for your analytical approach
AI that applies
AI analyzes FDA review histories for similar drugs and endpoints, identifies common statistical objections, and suggests pre-emptive analyses
How it works
The system ingests FDA review histories for similar drugs and endpoints as its primary data source. A language model processes the input by identifying relevant context, generating appropriate responses, and structuring the output to match the expected format and domain conventions. The results integrate into the practitioner's existing workflow — presenting recommendations, flags, or automated outputs alongside their normal working context.
What Changes
FDA precedent research is comprehensive; AI identifies how FDA statistical reviewers responded to similar designs and methods
What Stays
You prepare the statistical defense, anticipate follow-up questions, and represent the statistical case to regulators
Build your AI roadmap
Get a prioritized list of AI applications for your industry — ranked by impact and readiness.